This MedLibrary.org supplementary page on Polysaccharide encapsulated bacteria is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
Polysaccharide encapsulated bacteria, frequently referred to simply as encapsulated bacteria and less precisely called encapsulated organisms, are a group of bacteria that have an outer covering, a capsule, made of polysaccharide.
Contents |
Examples of encapsulated bacteria
- Haemophilus influenzae type B (Hib)1
- Streptococcus pneumoniae (pneumococcus)1
- Neisseria meningitides (meningococcus)1
- Group B streptococcus (GBS)1
- Salmonella typhi2
Role in disease
Many encapsulated bacteria are pathogens that lead to a significant amount of morbidity and mortality.3
Asplenia
People that lack a spleen, functionally (as in sickle cell disease45) or anatomically (due to a splenectomy or congenital absence), have been shown to be more susceptible to these pathogens. Therefore, it is standard medical practise to recommend vaccination.
People with asplenia are commonly offered vaccines against Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae; these vaccines can be remembered with the mnemonic: NHS.
Children
Young children do not have the ability to make antibodies to polysaccharide and are, therefore, more susceptible to encapsulated bacteria.3 This is especially so for children between 6months and 1year old,where maternalantibodies are depleted and endogeneous synthesis is not perfected yet.
See also
References
- ^ a b c d Jakobsen H, Jonsdottir I (2003). "Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?". Scand J Immunol 58 (2): 119–28. doi:. PMID 12869132.
- ^ Lee CJ, Lee LH, Koizumi K. Polysaccharide Vaccines for Prevention of Encapsulated Bacterial Infections: Part 1. Infect Med 19(3):127-133, 2002. Partial Free Text.
- ^ a b Vinuesa C, de Lucas C, Cook M (2001). "Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens". Postgrad Med J 77 (911): 562–9. doi:. PMID 11524513. Full Free Text.
- ^ Pearson H. "Sickle cell anemia and severe infections due to encapsulated bacteria". J Infect Dis 136 Suppl: S25–30. PMID 330779.
- ^ Wong W, Powars D, Chan L, Hiti A, Johnson C, Overturf G (1992). "Polysaccharide encapsulated bacterial infection in sickle cell anemia: a thirty year epidemiologic experience". Am J Hematol 39 (3): 176–82. doi:. PMID 1546714.
Wikipedia content modification information:
- This page was last modified on 29 August 2008, at 11:36.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Polysaccharide encapsulated bacteria".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.